Chantix May Raise Risk of Cardiovascular Events
The FDA has stated that Chantix, a drug prescribed to relieve the symptoms of smoking cessation, may increase the risk of having a major cardiovascular event.This data was collected during clinical trials and demonstrated that there was a higher occurrence of adverse cardiovascular events...